CN115768875A - 产生中脑多巴胺神经元的方法、中脑神经元及其用途 - Google Patents
产生中脑多巴胺神经元的方法、中脑神经元及其用途 Download PDFInfo
- Publication number
- CN115768875A CN115768875A CN202180037655.4A CN202180037655A CN115768875A CN 115768875 A CN115768875 A CN 115768875A CN 202180037655 A CN202180037655 A CN 202180037655A CN 115768875 A CN115768875 A CN 115768875A
- Authority
- CN
- China
- Prior art keywords
- days
- cells
- signaling
- inhibitor
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/113—Acidic fibroblast growth factor (aFGF, FGF-1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063004138P | 2020-04-02 | 2020-04-02 | |
| US63/004,138 | 2020-04-02 | ||
| PCT/US2021/025596 WO2021203009A1 (en) | 2020-04-02 | 2021-04-02 | Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115768875A true CN115768875A (zh) | 2023-03-07 |
Family
ID=77929755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180037655.4A Pending CN115768875A (zh) | 2020-04-02 | 2021-04-02 | 产生中脑多巴胺神经元的方法、中脑神经元及其用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230143486A1 (https=) |
| EP (1) | EP4127137A4 (https=) |
| JP (2) | JP2023520466A (https=) |
| KR (1) | KR20220164012A (https=) |
| CN (1) | CN115768875A (https=) |
| AU (1) | AU2021248640A1 (https=) |
| BR (1) | BR112022019881A2 (https=) |
| CA (1) | CA3177525A1 (https=) |
| IL (1) | IL296919A (https=) |
| MX (1) | MX2022012366A (https=) |
| WO (1) | WO2021203009A1 (https=) |
| ZA (1) | ZA202211266B (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025252180A1 (zh) * | 2024-06-05 | 2025-12-11 | 中国科学院脑科学与智能技术卓越创新中心 | 中脑多巴胺能祖细胞群的体外制备方法 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023220639A2 (en) * | 2022-05-10 | 2023-11-16 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for improved memory in the aging |
| US12565639B2 (en) | 2023-06-13 | 2026-03-03 | Aspen Neuroscience, Inc. | Methods for differentiating dopaminergic neurons from stem cells |
| WO2025166063A1 (en) | 2024-01-31 | 2025-08-07 | Bluerock Therapeutics Lp | Igfbp2 in cell culture |
| WO2026006245A1 (en) * | 2024-06-25 | 2026-01-02 | Bluerock Therapeutics Lp | Three-dimensional culturing of pluripotent stem cells for improved differentiability |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2614829A1 (en) * | 2012-01-11 | 2013-07-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons |
| CN104379731A (zh) * | 2011-11-04 | 2015-02-25 | 纪念斯隆-凯特琳癌症中心 | 用于植入的中脑多巴胺(da)神经元 |
| CN105209607A (zh) * | 2013-04-05 | 2015-12-30 | 大学健康网络 | 产生软骨细胞谱系细胞和/或类软骨组织的方法和组合物 |
| US20160115448A1 (en) * | 2013-04-26 | 2016-04-28 | Memorial Sloan-Kettering Cancer Center | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
| CN109996870A (zh) * | 2016-03-14 | 2019-07-09 | 新加坡科技研究局 | 从人多能干细胞产生中脑特异性类器官 |
-
2021
- 2021-04-02 CN CN202180037655.4A patent/CN115768875A/zh active Pending
- 2021-04-02 BR BR112022019881A patent/BR112022019881A2/pt unknown
- 2021-04-02 EP EP21781937.4A patent/EP4127137A4/en active Pending
- 2021-04-02 AU AU2021248640A patent/AU2021248640A1/en active Pending
- 2021-04-02 KR KR1020227038245A patent/KR20220164012A/ko active Pending
- 2021-04-02 IL IL296919A patent/IL296919A/en unknown
- 2021-04-02 WO PCT/US2021/025596 patent/WO2021203009A1/en not_active Ceased
- 2021-04-02 JP JP2022559927A patent/JP2023520466A/ja active Pending
- 2021-04-02 CA CA3177525A patent/CA3177525A1/en active Pending
- 2021-04-02 MX MX2022012366A patent/MX2022012366A/es unknown
-
2022
- 2022-09-30 US US17/956,957 patent/US20230143486A1/en active Pending
- 2022-10-13 ZA ZA2022/11266A patent/ZA202211266B/en unknown
-
2025
- 2025-09-26 JP JP2025160105A patent/JP2025184905A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104379731A (zh) * | 2011-11-04 | 2015-02-25 | 纪念斯隆-凯特琳癌症中心 | 用于植入的中脑多巴胺(da)神经元 |
| EP2614829A1 (en) * | 2012-01-11 | 2013-07-17 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons |
| CN105209607A (zh) * | 2013-04-05 | 2015-12-30 | 大学健康网络 | 产生软骨细胞谱系细胞和/或类软骨组织的方法和组合物 |
| US20160115448A1 (en) * | 2013-04-26 | 2016-04-28 | Memorial Sloan-Kettering Cancer Center | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
| CN109996870A (zh) * | 2016-03-14 | 2019-07-09 | 新加坡科技研究局 | 从人多能干细胞产生中脑特异性类器官 |
Non-Patent Citations (2)
| Title |
|---|
| BIN SONG等: "Human autologous iPSC–derived dopaminergic progenitors restore motor function in Parkinson’s disease models", J CLIN INVEST., vol. 130, no. 2, 3 February 2020 (2020-02-03), pages 904, XP093099657, DOI: 10.1172/JCI130767 * |
| TAE HWAN KWAK等: "Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson\'s disease modeling", STEM CELLS, vol. 38, no. 6, 28 February 2020 (2020-02-28), pages 729 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025252180A1 (zh) * | 2024-06-05 | 2025-12-11 | 中国科学院脑科学与智能技术卓越创新中心 | 中脑多巴胺能祖细胞群的体外制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220164012A (ko) | 2022-12-12 |
| WO2021203009A1 (en) | 2021-10-07 |
| US20230143486A1 (en) | 2023-05-11 |
| JP2025184905A (ja) | 2025-12-18 |
| IL296919A (en) | 2022-12-01 |
| CA3177525A1 (en) | 2021-10-07 |
| EP4127137A4 (en) | 2024-05-22 |
| JP2023520466A (ja) | 2023-05-17 |
| AU2021248640A1 (en) | 2022-10-27 |
| MX2022012366A (es) | 2022-12-15 |
| EP4127137A1 (en) | 2023-02-08 |
| ZA202211266B (en) | 2023-05-31 |
| BR112022019881A2 (pt) | 2022-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240400987A1 (en) | Methods of in vitro differentiation of midbrain dopamine (mda) neurons | |
| US20220177835A1 (en) | Methods of generating and isolating midbrain dopamine neurons | |
| US20230143486A1 (en) | Methods of generating midbrain dopamine neurons, midbrain neurons and uses thereof | |
| RU2855121C1 (ru) | Способы получения допаминовых нейронов среднего мозга, нейроны среднего мозга и их применение | |
| US20200332253A1 (en) | Derivation of somatotrophs from stem cells and uses thereof | |
| RU2856353C1 (ru) | Способы генерации и выделения дофаминовых нейронов среднего мозга | |
| HK40088175A (zh) | 产生中脑多巴胺神经元的方法、中脑神经元及其用途 | |
| WO2026039433A1 (en) | Midbrain dopaminergic neuron compositions and methods of use | |
| HK40075940A (zh) | 中脑多巴胺神经元的产生和分离方法 | |
| HK40081864A (en) | Methods of in vitro differentiation of midbrain dopamine (mda) neurons | |
| HK40082714A (en) | Methods of in vitro differentiation of midbrain dopamine (mda) neurons |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40088175 Country of ref document: HK |